Nicky Akbarian

Nicky Akbarian

Auto-generated profile, based on publicly available information

Nicky Akbarian

Faculty of Medicine Undergraduate Medical Education, University of Ottawa, Ottawa, Canada

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 June 2025 in Respiratory Medicine
Verified
Journal Article
Closed access
DCDaniel H. Cooper
Daniel H. Cooper
NANicky Akbarian
Nicky Akbarian
SAShawn D. Aaron
Shawn D. Aaron
VLVanessa Luks
Vanessa Luks
TKTetyana Kendzerska
Tetyana Kendzerska

1 June 2022 in Diabetes
Verified
Journal Article
Open access
EHEmily G. Hoffman
Emily G. Hoffman
SASara C. Atherley
Sara C. Atherley
NANicky Akbarian
Nicky Akbarian
NDNinoschka Dsouza
Ninoschka Dsouza
RLRichard Liggins
Richard Liggins
MRMichael Riddell
Michael Riddell
Background: Pancreatic islet remodelling in type 1 diabetes increases somatostatin (SST) expression, which inhibits glucagon counterregulation to hypoglycemia. Here, we characterized islet morphology and hormone composition in a rodent model of insulin-deficient type 2 diabetes (T2D) . Methods: Hypoinsulinemic T2D was induced in 8-9-week-old, male, Sprague-Dawley rats (n=4) via 3 weeks of high-fat feeding and a low-dose injection of streptozotocin (STZ; 35 mg/kg) . After 2 weeks of basal insulin treatment, pancreas tissue was extracted from T2D and healthy control (n=5) rats for immunohistochemical staining of representative islets. Results: Fasted plasma C-peptide levels of hyperglycemic (24.8±3.3 mmol/l) T2D rats were reduced by ∼44% (624±64 vs. 1107±121 pmol/l; p<0.001) , while glucagon was unchanged (75±31 vs. 98±39 pg/ml) . Fractional islet area of glucagon and SST were elevated by 40% (21±15 vs. 15±10%; p<0.001) and 83% (11±8 vs. 6±5%; p<0.001) , respectively, as compared to control rats (Figure) , which was most pronounced in small and medium-sized islets. Conclusions: Fractional area expression of glucagon and SST increased per islet in insulin-treated rats with advanced T2D. These findings may help account for the increase in SST signaling that underscores defective glucagon counterregulation to hypoglycemia in insulin-deficient diabetic states. Disclosure: E. G. Hoffman: None. S. C. Atherley: None. N. Akbarian: None. N. Dsouza: None. R. Liggins: Employee; Zucara Therapeutics, Stock/Shareholder; Zucara Therapeutics. M. Riddell: Advisory Panel; Zealand Pharma A/S, Zucara Therapeutics, Consultant; Eli Lilly and Company, Jaeb Center for Health Research, Speaker’s Bureau; Dexcom, Inc., Eli Lilly and Company, Novo Nordisk. Funding: GlycoNet

3 October 2026 in Current Cardiovascular Risk Reports
Verified
Journal Article
Closed access
PDF file
NANicky Akbarian
Nicky Akbarian
DPDonna Pettey
Donna Pettey
MRMaryann Roebuck
Maryann Roebuck